tiprankstipranks
Trending News
More News >
Definium Therapeutics (DFTX)
NASDAQ:DFTX

Compare Definium Therapeutics (DFTX) vs. Competitors

Compare
2,209 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Definium Therapeutics
$18.66
$1.86B
-6.51
176.69%
11 Buy
0 Hold
0 Sell
Strong Buy
AnaptysBio
$64.72
$1.86B
-101.81
254.95%
8 Buy
1 Hold
0 Sell
Strong Buy
Enliven Therapeutics
$30.05
$1.80B
-8.42
38.77%
4 Buy
0 Hold
0 Sell
Strong Buy
Tyra Bioscience
$38.18
$2.06B
-13.06
239.58%
10 Buy
0 Hold
0 Sell
Strong Buy
Biohaven Ltd.
$8.96
$1.35B
-1.64
-68.31%
9 Buy
3 Hold
0 Sell
Strong Buy
Inhibrx Biosciences Inc
$85.32
$943.45M
332.06%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DFTX
Definium Therapeutics
18.40
11.48
165.90%
ANAB
AnaptysBio
62.37
43.66
233.32%
ELVN
Enliven Therapeutics
29.03
6.57
29.25%
TYRA
Tyra Bioscience
37.15
26.50
248.83%
BHVN
Biohaven Ltd.
8.93
-22.11
-71.23%
INBX
Inhibrx Biosciences Inc
60.92
46.20
313.86%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts